Get a glimpse into our company and investor data—powered by the PitchBook Platform
AngelLATEST DEAL TYPE
$50KLATEST DEAL AMOUNT
Developer of pharmaceutical products for treating ultra-rare orphan diseases. The company specializes in the development and commercialization of pharmaceutical products to address the needs of patients with ultra-rare orphan diseases.